Reaction

Emphysematous Cholecystitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 50 reports · 2 co-occurring drugs

As of the last recalculation, Emphysematous Cholecystitis appears in 50 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is AZACITIDINE FOR (PRR 401.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Azacitidine For13401.7402.0
Azacitidine13246.1246.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.